| Patent | Date |
|---|
Precision activation of HIV-specific CTLS to eliminate reactivated latent T cells
Grant 11,407,806 - Goldstein , et al. August 9, 2 | 2022-08-09 |
Compounds And Methods For Treatment Of Bacterial Infections
App 20220234995 - Almo; Steven C. ; et al. | 2022-07-28 |
Antibody-based Method To Identify, Purify, And Manipulate Cell Types And Processes
App 20220227886 - Buelow; Hannes E. ; et al. | 2022-07-21 |
Prevention and treatment of viral infections
Grant 11,382,919 - Herold , et al. July 12, 2 | 2022-07-12 |
Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereof
Grant 11,339,201 - Garrett-Thomson , et al. May 24, 2 | 2022-05-24 |
Broad spectrum viral inhibitor
Grant 11,279,728 - Almo , et al. March 22, 2 | 2022-03-22 |
Mutant Variants Of Pd-1 Receptor With Selective Binding To Pd-l1 And Uses Thereof
App 20220047729 - Fiser; Andras ; et al. | 2022-02-17 |
Methods for high throughput receptor:ligand identification
Grant 11,226,339 - Almo , et al. January 18, 2 | 2022-01-18 |
Tmigd2 And Its Derivatives As Blockers Or Binders Of Cancer-expressed Hhla2 For Immunotherapies
App 20210388052 - Zang; Xingxing ; et al. | 2021-12-16 |
Syntac Polypeptides And Uses Thereof
App 20210238254 - Seidel, III; Ronald D. ; et al. | 2021-08-05 |
Precision Activation Of Hiv-specific Ctls To Eliminate Reactivated Latent T Cells
App 20210107967 - Goldstein; Harris ; et al. | 2021-04-15 |
Syntac Polypeptides And Uses Thereof
App 20210047384 - Seidel, III; Ronald D. ; et al. | 2021-02-18 |
TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies
Grant 10,882,893 - Zang , et al. January 5, 2 | 2021-01-05 |
Prevention And Treatment Of Viral Infections
App 20200383994 - Herold; Betsy C. ; et al. | 2020-12-10 |
Syntac Polypeptides And Uses Thereof
App 20200377569 - Seidel, III; Ronald D. ; et al. | 2020-12-03 |
Broad Spectrum Viral Inhibitor
App 20200361982 - Almo; Steven C. ; et al. | 2020-11-19 |
Tumor necrosis factor 1B (TNF-1B) mutants and methods of use thereof to screen for candidate therapeutic compounds
Grant 10,717,776 - Almo , et al. | 2020-07-21 |
Methods For High Throughput Receptor:ligand Identification
App 20200011875 - Almo; Steven C. ; et al. | 2020-01-09 |
Tmigd2 And Its Derivatives As Blockers Or Binders Of Cancer-expressed Hhla2 For Immunotherapies
App 20190263886 - Zang; Xingxing ; et al. | 2019-08-29 |
Variant Pd-l1 Polypeptides, T-cell Modulatory Multimeric Polypeptides, And Methods Of Use Thereof
App 20190153065 - Garrett-Thomson; Sarah C. ; et al. | 2019-05-23 |
TMIGD2 and its derivatives as blockers or binders of cancer-expressed HHLA2 for immunotherapies
Grant 10,280,208 - Zang , et al. | 2019-05-07 |
Syntac Polypeptides And Uses Thereof
App 20180282392 - Seidel, III; Ronald D. ; et al. | 2018-10-04 |
Therapeutic Tnfr-1b Targets And Uses Thereof
App 20180273604 - Almo; Steven C. ; et al. | 2018-09-27 |
Methods for high throughput receptor:ligand identification
Grant 10,048,271 - Almo , et al. August 14, 2 | 2018-08-14 |
Tmigd2 And Its Derivatives As Blockers Or Binders Of Cancer-expressed Hhla2 For Immunotherapies
App 20170174742 - Zang; Xingxing ; et al. | 2017-06-22 |
Cellular Platform For Rapid And Comprehensive T-cell Immunomonitoring
App 20170176435 - Seidell, III; Ronald D. ; et al. | 2017-06-22 |
Syntac Polypeptides And Uses Thereof
App 20170058015 - Seidel, III; Ronald D. ; et al. | 2017-03-02 |
Methods For High Throughput Receptor:ligand Identification
App 20160011204 - Almo; Steven C. ; et al. | 2016-01-14 |
A Selective High-affinity Immune Stimulatory Reagent And Uses Thereof
App 20150368316 - LAZAR-MOLNAR; Eszter ; et al. | 2015-12-24 |
Method For Determining Receptor-ligand Pairs
App 20120078530 - Almo; Steven C. ; et al. | 2012-03-29 |
| 